BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35717719)

  • 1. Synergistic Neuroprotection by a PAF Antagonist Plus a Docosanoid in Experimental Ischemic Stroke: Dose-Response and Therapeutic Window.
    Reid MM; Obenaus A; Mukherjee PK; Khoutorova L; Roque CR; Petasis NA; Oria RB; Belayev L; Bazan NG
    J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106585. PubMed ID: 35717719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking pro-inflammatory platelet-activating factor receptors and activating cell survival pathways: A novel therapeutic strategy in experimental ischemic stroke.
    Belayev L; Obenaus A; Mukherjee PK; Knott EJ; Khoutorova L; Reid MM; Roque CR; Nguyen L; Lee JB; Petasis NA; Oria RB; Bazan NG
    Brain Circ; 2020; 6(4):260-268. PubMed ID: 33506149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Lipid Mediators as a Promising Therapeutic Strategy for Ischemic Stroke.
    Belayev L; Reid MM; Bazan NG
    Med Res Arch; 2023 Jan; 11(1):. PubMed ID: 36777192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke.
    Bazan NG; Eady TN; Khoutorova L; Atkins KD; Hong S; Lu Y; Zhang C; Jun B; Obenaus A; Fredman G; Zhu M; Winkler JW; Petasis NA; Serhan CN; Belayev L
    Exp Neurol; 2012 Jul; 236(1):122-30. PubMed ID: 22542947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia.
    Belayev L; Khoutorova L; Atkins K; Gordon WC; Alvarez-Builla J; Bazan NG
    Exp Neurol; 2008 Dec; 214(2):253-8. PubMed ID: 18793637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAU-0901, a novel platelet-activating factor receptor antagonist, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat.
    Belayev L; Khoutorova L; Atkins K; Cherqui A; Alvarez-Builla J; Bazan NG
    Brain Res; 2009 Feb; 1253():184-90. PubMed ID: 19070607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docosanoids Promote Neurogenesis and Angiogenesis, Blood-Brain Barrier Integrity, Penumbra Protection, and Neurobehavioral Recovery After Experimental Ischemic Stroke.
    Belayev L; Hong SH; Menghani H; Marcell SJ; Obenaus A; Freitas RS; Khoutorova L; Balaszczuk V; Jun B; Oriá RB; Bazan NG
    Mol Neurobiol; 2018 Aug; 55(8):7090-7106. PubMed ID: 29858774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NPD1 Plus RvD1 Mediated Ischemic Stroke Penumbra Protection Increases Expression of Pro-homeostatic Microglial and Astrocyte Genes.
    Reid MM; Kautzmann MI; Andrew G; Obenaus A; Mukherjee PK; Khoutorova L; Ji JX; Roque CR; Oria RB; Habeb BF; Belayev L; Bazan NG
    Cell Mol Neurobiol; 2023 Oct; 43(7):3555-3573. PubMed ID: 37270727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior Neuroprotective Efficacy of LAU-0901, a Novel Platelet-Activating Factor Antagonist, in Experimental Stroke.
    Belayev L; Eady TN; Khoutorova L; Atkins KD; Obenaus A; Cordoba M; Vaquero JJ; Alvarez-Builla J; Bazan NG
    Transl Stroke Res; 2012 Mar; 3(1):154-63. PubMed ID: 22408693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docosahexaenoic acid signaling modulates cell survival in experimental ischemic stroke penumbra and initiates long-term repair in young and aged rats.
    Eady TN; Belayev L; Khoutorova L; Atkins KD; Zhang C; Bazan NG
    PLoS One; 2012; 7(10):e46151. PubMed ID: 23118851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
    Belayev L; Liu Y; Zhao W; Busto R; Ginsberg MD
    Stroke; 2001 Feb; 32(2):553-60. PubMed ID: 11157196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats.
    Gupta S; Sharma U; Jagannathan NR; Gupta YK
    Exp Neurol; 2017 Feb; 288():25-37. PubMed ID: 27794423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docosahexaenoic acid complexed to human albumin in experimental stroke: neuroprotective efficacy with a wide therapeutic window.
    Eady TN; Khoutorova L; Atkins KD; Bazan NG; Belayev L
    Exp Transl Stroke Med; 2012 Sep; 4(1):19. PubMed ID: 22980673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docosahexaenoic Acid therapy of experimental ischemic stroke.
    Belayev L; Khoutorova L; Atkins KD; Eady TN; Hong S; Lu Y; Obenaus A; Bazan NG
    Transl Stroke Res; 2011 Mar; 2(1):33-41. PubMed ID: 21423332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid complexed to albumin provides neuroprotection after experimental stroke in aged rats.
    Eady TN; Khoutorova L; Obenaus A; Mohd-Yusof A; Bazan NG; Belayev L
    Neurobiol Dis; 2014 Feb; 62():1-7. PubMed ID: 24063996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NPD1 rapidly targets mitochondria-mediated apoptosis after acute injection protecting brain against ischemic injury.
    Zirpoli H; Sosunov SA; Niatsetskaya ZV; Mayurasakorn K; Manual Kollareth DJ; Serhan CN; Ten VS; Deckelbaum RJ
    Exp Neurol; 2021 Jan; 335():113495. PubMed ID: 33038416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519.
    Williams AJ; Berti R; Dave JR; Elliot PJ; Adams J; Tortella FC
    Stroke; 2004 May; 35(5):1186-91. PubMed ID: 15060320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effect of Macrophage Migration Inhibitory Factor (MIF) in a Mouse Model of Ischemic Stroke.
    Kim JA; Kim YY; Lee SH; Jung C; Kim MH; Kim DY
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotectin D1 attenuates brain damage induced by transient middle cerebral artery occlusion in rats through TRPC6/CREB pathways.
    Yao C; Zhang J; Chen F; Lin Y
    Mol Med Rep; 2013 Aug; 8(2):543-50. PubMed ID: 23799606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.